PCOS is Now PMOS: What the Name Change Means for You

I've been writing about PCOS for years. I've explained the symptoms, the diets, the supplements, the frustration of delayed diagnosis, and the heartbreak of being told "it's all in your head." I've read thousands of comments and emails from women navigating this condition with too little support and too much confusion.

Now the name has changed. And honestly? It's about time.

On May 12, 2026, The Lancet published a landmark paper announcing that Polycystic Ovary Syndrome is now Polyendocrine Metabolic Ovarian Syndrome — PMOS (Teede et al., 2026). The change was led by Professor Helena Teede of Monash University, endorsed by 56 patient and professional organisations including the Endocrine Society, and shaped by the largest disease-renaming survey in history: 22,000 responses collected over 14 years.

This isn't just a cosmetic rebrand. The name change is the result of decades of research, thousands of patient voices, and a growing realisation that the old name was actively causing harm. If you've been diagnosed with PCOS — or you're trying to understand what PMOS means for you — I'm going to walk you through everything. No jargon, no panic. Just clear answers.

What Changed and When

Let me be specific about what actually happened here, because some of the headlines have been vague.

The facts:

• Old name: Polycystic Ovary Syndrome (PCOS)
• New name: Polyendocrine Metabolic Ovarian Syndrome (PMOS)
• Announced: May 12, 2026, in The Lancet
• Led by: Professor Helena Teede, Monash University, Australia
• Endorsed by: 56 organisations including the Endocrine Society
• Survey responses: 22,000 people over 14 years — the largest disease-renaming process in history
• Transition period: 3 years — full implementation expected by the 2028 International Guideline update
• Scope: Affects 1 in 8 women worldwide — approximately 170 million people

The vote wasn't close. Out of 90 voters, 88 supported PMOS. That kind of consensus in medicine is rare. It tells you how broadly felt the problems with the old name were — from patients, endocrinologists, gynaecologists, and primary care doctors alike.

During the transition, both names will be used. Your doctor may still write "PCOS" on your chart for a while, and that's completely fine. The medical records systems, diagnostic codes (ICD), and clinical guidelines will all update gradually over the next three years.

As Lorna Berry, an Australian woman living with the condition, put it: "This is about accountability and progress. It is about my daughters, their daughters, and the countless women yet to be born." That captures something I feel strongly about too — this isn't just about us. It's about making sure the next generation of patients gets better care from the start.

Why PCOS Was a Misleading Name

I've lost count of how many readers have told me some version of: "My doctor said I don't have cysts, so it can't be PCOS." Or the reverse: "I have ovarian cysts, so I must have PCOS." Both are wrong, and both are direct consequences of a bad name.

Here's the core problem: research has confirmed there is no increase in abnormal cysts on the ovary in PCOS (Dewailly et al., 2014). What were called "cysts" are actually follicles — small fluid-filled sacs that contain developing eggs. They're a symptom of the hormonal imbalance, not the cause. And many people with PMOS don't have them at all.

The word "polycystic" in the name created a cascade of problems that lasted for decades:

Diagnostic confusion. Doctors would order ultrasounds, check for follicles, and if the ovaries looked "normal," they'd dismiss the possibility of PCOS entirely. Meanwhile, the patient's insulin resistance, irregular periods, and hormonal imbalances went unchecked. I've heard this story from hundreds of readers — being sent away for years before someone finally ran the right blood tests.

Self-misdiagnosis. People with benign ovarian cysts — which are extremely common and often unrelated to PCOS — would assume they had the condition. This created unnecessary anxiety and, worse, meant they might not investigate other causes for their symptoms. Conversely, people with genuine PMOS who happened to have no visible follicles on ultrasound were told they were fine.

Narrow treatment focus. When a condition is named after an ovarian feature, treatment naturally gravitates toward the ovaries. Doctors prescribed the pill to "regulate" periods without addressing the underlying metabolic dysfunction. The insulin resistance that drives so many PMOS symptoms was treated as an afterthought — if it was tested at all.

Research distortion. Study after study focused on ovarian morphology — counting follicles, measuring ovary size — rather than investigating the hormonal and metabolic mechanisms that actually drive the condition. The name shaped the research agenda, and the research shaped the treatments. It was a feedback loop that held back progress.

Delayed diagnosis. The World Health Organisation reports that 70% of people with PMOS remain undiagnosed. That staggering number isn't just about access to healthcare — it's about a name that makes the condition sound like it's all about cysts, when it's so much more.

Rachel Morman, Chair of Verity (the UK's PCOS charity), said it well: "It is fantastic that the new name now leads with hormones and recognizes the metabolic dimension of the condition."

Professor Teede and her team spent 14 years gathering evidence and patient input before proposing the change. This wasn't a snap decision — it was a slow, deliberate correction of something the medical community had gotten wrong since the condition was first named in 1935 by Stein and Leventhal.

What PMOS Actually Means

Let me break down each word, because each one carries specific meaning:

Polyendocrine

"Poly" means many. "Endocrine" refers to the hormone system. PMOS affects multiple hormone systems — not just the reproductive hormones most people associate with it. The thyroid, adrenal glands, and insulin-producing pancreas are all involved. This is why PMOS symptoms are so varied: they reflect disruptions across several interconnected hormonal pathways.

I've written about how this connects to FSH levels and other hormonal markers. When you understand that PMOS is a polyendocrine condition, it makes sense why so many different hormone tests matter — not just the ones related to your ovaries.

Metabolic

This is the biggest shift. By putting "Metabolic" in the name, the medical community is acknowledging something patients have known for years: PMOS is fundamentally a metabolic condition. Insulin resistance affects an estimated 65–80% of people with PMOS, regardless of body weight (Moran et al., 2010).

The metabolic dimension explains why:

• Weight management feels harder with PMOS than it should
• Carrying weight around the midsection is so common
• Cardiovascular risk is elevated
• Type 2 diabetes risk is significantly higher
• Dietary changes can have such a dramatic impact on symptoms

If you've been following my PMOS diet recommendations, you already know how central metabolic health is to managing symptoms. The name finally reflects that reality.

Ovarian

The condition primarily affects people with ovaries, and the ovaries remain part of the picture — menstrual irregularity, anovulation, and follicle development are still key symptoms. But "ovarian" is now just one part of a more complete name, rather than the entire focus. This should help doctors see the whole condition, not just one organ.

Syndrome

A syndrome is a collection of related symptoms that occur together. PMOS doesn't have one single cause or one definitive test. It's a pattern — and the new name helps clinicians think about the full pattern, including the metabolic and hormonal features they might have previously overlooked.

The bottom line: The only letter that changed from PCOS to PMOS is the C becoming an M. But that single letter swap represents a completely different way of understanding the condition. From "cysts" to "metabolic" — from a narrow, misleading label to one that actually captures what researchers and patients have been saying for years.

Does the Name Change Your Diagnosis?

No. If you were diagnosed with PCOS, you now have PMOS. It's the same condition with a more accurate name. You don't need a new diagnosis, new blood tests, or a new doctor's visit.

Here's what will change — and on what timeline:

• Medical records: Terminology will update gradually during the 3-year transition. Some systems may still show "PCOS" for a while.
• Diagnostic codes: The International Classification of Diseases (ICD) codes will be revised to reflect PMOS.
• Clinical guidelines: The 2028 International Guideline update will use PMOS terminology throughout.
• Your treatment: Whether that's myo-inositol, metformin, dietary changes, hormonal contraception, or other approaches — absolutely unchanged.

If your doctor hasn't mentioned the change yet, don't worry. The announcement is brand new, and not every clinician will have seen it immediately. You can bring it up at your next appointment. You might even share the Lancet reference: Teede, H.J. et al. (2026), "Polyendocrine Metabolic Ovarian Syndrome: renaming PCOS."

I'll say this though — if your doctor dismisses the name change or doesn't seem aware of the metabolic implications, that might be a signal to seek out a specialist. An endocrinologist who understands the full scope of PMOS will serve you better than a provider who still thinks of it as "just a cyst thing."

What This Means for Your Care

This is where I think the name change actually matters most. Not in the label, but in how it changes the conversation between you and your doctor.

For years, I've heard from readers whose doctors fixated on the "cystic" part. They'd get an ultrasound, be told their ovaries looked "normal," and be sent away without further investigation. Or they'd be told the only treatment was the pill, because the focus was on regulating periods rather than addressing underlying metabolic issues.

PMOS puts the metabolic and endocrine aspects front and centre. In my experience writing about this condition, I believe that should mean:

Better screening. Doctors are more likely to test insulin resistance, lipid panels, HbA1c, and cardiovascular risk markers — not just check for follicles on an ultrasound. If the name says "metabolic," the tests should follow.

Broader treatment conversations. Discussions about diet, exercise, and metabolic health should happen alongside or even before hormonal contraception. I've been saying this for years: PMOS management is not just about the pill.

Earlier diagnosis. If the name doesn't require "cysts" to make sense, fewer people will fall through the cracks. A teenager with irregular periods and insulin resistance should be screened — even if her ovaries look normal on ultrasound.

Research direction. Funding and studies will increasingly focus on the metabolic mechanisms driving PMOS. This could lead to better-targeted treatments — not just symptom management, but addressing root causes. The kind of research that might eventually help us understand why hair loss happens in PMOS, or why some people develop severe acne while others don't.

Patient empowerment. When you understand that PMOS is a metabolic condition, you can advocate for the right tests, the right referrals, and the right conversations. You're not just asking about your ovaries — you're asking about your whole endocrine system.

I'm cautiously optimistic about all of this. A name change alone doesn't fix a broken system. But it's a strong signal that the medical establishment is catching up to what patients have been saying for decades.

What Stays the Same

I don't want anyone to read this and panic. Let me be clear about what doesn't change:

• Your symptoms: PMOS symptoms are identical to what was called PCOS — irregular periods, acne, hair loss, weight gain, fertility challenges
• Your treatments: Metformin, the pill, spironolactone, myo-inositol, dietary approaches — all unchanged
• Your fertility journey: Whether you're trying to conceive now or planning ahead, getting pregnant with PMOS follows the same protocols
• Your supplements: CoQ10 for egg quality, inositol, vitamin D — the evidence base hasn't changed
• The support community: Every PMOS support group, every resource, every article I've written still applies
• Your experience: Nothing about what you've been through changes. The name just better describes it.

I'll be updating my content over the coming months to reflect the new terminology, but the advice, the research, and the support stays the same. You're not starting over. You're just getting a better name for what you've always had.

🌿 Dani Recommends

Whether you call it PCOS or PMOS, the fundamentals of managing the condition haven't changed. If you're newly diagnosed or re-evaluating your approach, here's where I'd start:

• Get your insulin resistance tested — it's the metabolic core of PMOS and it's still too often overlooked
• Download my PMOS-friendly meal plan — designed around blood sugar stability
• Explore myo-inositol — one of the most evidence-backed supplements for PMOS
• Check out these breakfast ideas that won't spike your blood sugar
• Read up on CoQ10 and egg quality if you're thinking about fertility

These are the same recommendations I've always made. The name changed. The evidence-based advice didn't.

Frequently Asked Questions

Do I need to get re-diagnosed with PMOS?

No. If you were previously diagnosed with PCOS, that diagnosis now falls under PMOS. It's the same condition with a new, more accurate name. No additional tests or appointments are needed.

Will my insurance or medical records be affected?

During the 3-year transition period, both PCOS and PMOS terminology will be accepted. Diagnostic codes will be updated gradually. Your coverage and treatment plans are not affected by the name change.

Should I tell my doctor about the name change?

You can, especially if your next appointment is soon. Some doctors may not have seen the announcement yet. Sharing the Lancet reference (Teede et al., 2026) can be a helpful way to start the conversation. It also signals to your provider that you're informed and engaged in your care.

Does PMOS affect men too?

Research into a male equivalent is underway, but the current diagnosis applies to people with ovaries. Including male patients in the rename would have delayed the change significantly, so the decision was made to address this separately. The Endocrine Society has indicated this will be explored in future guideline updates.

Will treatment guidelines change because of the new name?

The 2028 International Guideline update will incorporate PMOS terminology. However, the underlying treatment approaches — lifestyle management, insulin sensitisation, hormonal regulation — are expected to remain consistent. If anything, the name change may encourage more emphasis on metabolic screening and management.

Why wasn't the name changed to something completely different?

PMOS was chosen because it's medically accurate while keeping the acronym close to PCOS — only one letter changes. A completely different name would have caused more confusion during the transition and made it harder for patients to recognise their condition. The survey of 22,000 people showed strong preference for a name that maintained recognisability while fixing the "cystic" problem.

Does the name change affect how PMOS is researched?

Yes, and this is one of the most exciting aspects. By removing "polycystic" from the name, researchers are encouraged to study the metabolic and endocrine dimensions more broadly, rather than focusing narrowly on ovarian morphology. This could shift funding priorities and open up new lines of investigation into the root causes of PMOS.

References

Dewailly, D., Lujan, M.E., Carmina, E., et al. (2014). Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Human Reproduction Update, 20(3), 334–352.

Teede, H.J., Tay, C.T., Laven, J.J.E., et al. (2026). Polyendocrine Metabolic Ovarian Syndrome: renaming PCOS. The Lancet. Published online May 12, 2026.

Endocrine Society. (2026). Endocrine Society endorses renaming of PCOS to PMOS. Press release, May 12, 2026.

Moran, L.J., Misso, M.L., Wild, R.A., & Norman, R.J. (2010). Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update, 16(4), 347–363.

World Health Organization. (2025). Polycystic ovary syndrome fact sheet. Retrieved from WHO.int.

Norman, R.J., Dewailly, D., Legro, R.S., & Hickey, T.E. (2007). Polycystic ovary syndrome. The Lancet, 370(9588), 685–697.

Medical Disclaimer: The information on this website is provided for educational purposes only and should not be treated as medical advice. Fertilitys.com does not provide medical diagnosis or treatment. You should not rely on the information provided as a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor or qualified healthcare provider with any questions you may have regarding a medical condition. If you think you may have a medical emergency, call your doctor or emergency services immediately.

Cite This Page: Dani, Fertilitys.com (2026). "PCOS is Now PMOS: What the Name Change Means for You." Retrieved from fertilitys.com/pcos/pcos-name-change-pmos/

Written by

Share

Copied